NZ HERALD: The Herald’s medical reporter, Martin Johnston, has written a balanced account on where we are with the great PSA debate. READ MORE>
Archive for the ‘SCREENING and DIAGNOSIS’ Category
Posted in PSA tests, tagged blood test, blood tests, medical checkups, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate-specific antigen, PSA, PSA test, Screening debate on April 6, 2011 | 1 Comment »
PROSTABLOG NZ: The PSA test may get a bad rap from epidemiologists and the Ministry of Health, but so far as I’m concerned it’s a winner.
It’s a reliable post-treatment indicator of whether your prostate cancer is coming back or not, and I’ve just had my two-year test – and it remains undetectable.
That’s very good news, so far as I can discern. My reading of things prostate tells me the two-year mark is a crucial one, a time when recurrence is most likely to rear its unwelcome head.
That doesn’t mean I’m cured. There’s a long way to go before that marker, perhaps a decade.
The only thing I’m not sure about is the fact my PSA never registered much (let alone any change) prior to my diagnosis in 2008.
Does that mean post-surgery PSA tests won’t work on me either.
Nah, let’s not dwell on it.
Posted in New tests, tagged biological signals, Biomarkers, cancer research, catheter, diagnostic tests, lab test, Oxford Gene Technology, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, REUTERS, Screening debate on October 5, 2010 | Leave a Comment »
REUTERS: British scientists say they have developed a lab test that can accurately distinguish prostate cancer from healthy tissue and other prostate conditions. READ MORE>
Researchers at a genetics and diagnostics firm Oxford Gene Technology say the set of biological signals, or biomarkers, they have identified was able to distinguish healthy tissue and benign prostate disease from prostate cancer with 90 percent accuracy in initial laboratory sample tests.
A full test for use in doctors’ clinics is likely to be at least five years off, they said, but their pilot study testing around 130 samples showed encouraging results in a disease area where more accurate diagnostic tests are sorely needed.
Posted in PSA tests, Screening debate, tagged Associated Press, New health insurance policies, Obama administration's health care overhaul, President Obama's new preventive health insurance, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, prostate-specific antigen, PSA, Screening debate on September 27, 2010 | Leave a Comment »
ASSOCIATED PRESS: Screening for prostate cancer will not be included in President Obama’s new preventive health insurance next year. READ MORE>
New health insurance policies beginning on or after September 23 must cover — without charge — preventive care that’s backed up by the best scientific evidence. Most people will see this benefit, part of the Obama administration’s health care overhaul, starting January 1.
The list includes tests strongly recommended by the US Preventive Services Task Force, an independent advisory panel that evaluates research.
Of note for men: Screening for prostate cancer isn’t included on the list because its benefits haven’t been conclusively shown by the best research, at least to the high level required by the law.
Posted in Diagnosis, tagged decision aids, digital diagnosis, electronic decision-support tool, epidemiologists, evidence-based medicine, Harbour Health PHO, Lannes Johnson, management of prostate health, medical checkups, NZ Doctor, NZ Health Select Committee, oncologists, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, prostate-specific antigen, PSA, PSA test, Screening debate, urologists on September 16, 2010 | Leave a Comment »
NZ DOCTOR: Harbour Health PHO told the NZ Health Select Committee yesterday [15 September] it is just weeks away from testing an electronic decision-support tool, which describes a care pathway for the assessment and management of prostate health. READ MORE>
Men and their GPs are often confused by the conflicting messages about prostate cancer, Dr Lannes Johnson (Harbour Health PHO medical director) told the committee.
“On one hand we tell GPs not to screen for prostate cancer; on the other, we say, every man has the right to testing and advice.
“The controversy has not been resolved by the evidence-based medicine approach…But sensible decisions can be made in primary care even without consensus between urologists, oncologists or epidemiologists.
“We really cannot leave things as they are.”
PROSTABLOG NZ: Decision aids to assist men make choices about prostate cancer treatment have been around a while, but have only recently been adapted for use via the internet.
The Australians announced in July good results with one designed for men with prostate cancer in their families. READ MORE>